These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1615482)

  • 1. A novel functional assay of protein C in human plasma and its comparison with amidolytic and anticoagulant assays.
    Guglielmone HA; Vides MA
    Thromb Haemost; 1992 Jan; 67(1):46-9. PubMed ID: 1615482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting APC-resistant factor V: a functional method without plasma dilution.
    Rylatt DB; Hohnen-Behrens C; Pilgrim RL; Dickeson LE; Neal M; Exner T
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):359-66. PubMed ID: 10493217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional assays of protein C: comparison of two snake-venom assays with two thrombin assays.
    Franchi F; Tripodi A; Valsecchi C; Mannucci PM
    Thromb Haemost; 1988 Oct; 60(2):145-7. PubMed ID: 3217914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new venom-based clotting assay of protein C.
    Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
    Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Automated assay method for protein C anticoagulant activity].
    Iijima K; Kameo Y; Hara I; Murakami F; Nakamura K
    Rinsho Byori; 1992 Jun; 40(6):645-8. PubMed ID: 1513037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S.
    D'Angelo SV; Gilardoni F; D'Angelo A
    Thromb Haemost; 1989 Nov; 62(3):861-7. PubMed ID: 2531939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S.
    van Wijnen M; van 't Veer C; Meijers JC; Bertina RM; Bouma BN
    Thromb Haemost; 1998 Dec; 80(6):930-5. PubMed ID: 9869163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of agreement of chromogenic and clotting assays for factor X and protein C in warfarinised plasma.
    Han P; Fung KP; Rahdakrishnan U
    Thromb Haemost; 1991 Apr; 65(4):360-3. PubMed ID: 2057917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway.
    Robert A; Eschwège V; Hameg H; Drouet L; Aillaud MF
    Thromb Haemost; 1996 Apr; 75(4):562-6. PubMed ID: 8743179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
    Johnstone IB; Martin CA
    Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays.
    España F; Estellés A; Aznar J; Gilabert J
    Thromb Res; 1986 Dec; 44(6):771-82. PubMed ID: 3798419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
    Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
    Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
    Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
    Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of chromogenic substrate on protein C activity assay--in patients treated with warfarin].
    Sakata T; Hatsuyama H; Kitamura T; Uchida K; Katayama Y; Matsuyama T
    Rinsho Byori; 1990 Aug; 38(8):937-41. PubMed ID: 2232257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of a functional assay for protein C.
    Triplett DA; Sandquist DS; Musgrave KA
    Hematol Pathol; 1987; 1(4):239-47. PubMed ID: 3143709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic assay for protein C determination in horses.
    Welles EG; Prasse KW; Duncan A; Morris MJ
    Am J Vet Res; 1990 Jul; 51(7):1075-9. PubMed ID: 2389886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.